A global partnership to accelerate the fight against HIV/AIDS

CREATING A FAST LANE FOR CHANGE

New interventions and technologies in the fight against HIV/AIDS

In the fight against HIV/AIDS hundreds of simple, innovative, high-impact ideas

are conceived of every day. Yet a dearth of funds means

many of these lifesaving interventions never have the chance to fully develop.

As a result, 1.26 million young people are infected

with HIV each year. The UNICEF HIV/AIDS Innovation Fund seeks to help change this. By harnessing the greatest minds — and

investing in interventions and technologies

with the highest potential to break through bottlenecks and achieve scale —

the Fund will help realize an HIV-free generation by 2015. Join us in the next phase of the fight against HIV/AIDS.

MOVING TOWARD AN HIV-FREE GENERATION

1.26 million children and young people are newly infected with HIV each year. By 2015, the global community aims to reduce this number by 50%.

Reduce new youth infection by 30%Reduce new infant infection by 90%

Each figure represents 10,000 children newly infected each year.

To do this UNICEF and partners will:

From 370,000 to 37,000

From 890,000 to 623,000

STAGING INNOVATIONS FOR SCALE-UP

The UNICEF HIV/AIDS Innovation Fund brings together top HIV experts with diverse business and philanthropic leaders to invest in high-impact, low-cost interventions and technologies that have the potential to help us realize an HIV-free generation.

How it works:

Working in more than 150 devel-oping countries, UNICEF draws from a vast network of partners to source the most innovative ideas that address unmet needs and service hard-to reach populations. 1

Projects with the highest potential are recommend-ed for seed funding by the Advisory Committee.

2

The Fund incubates these ideas, providing financing and expertise through the pilot phase.

3

UNICEF works with governments, NGOs, academia, and multilateral partners to stage the most successful projects for scale, breaking bottlenecks, boosting capacity, and encourag- ing new commitments.4Funders and partners receive narrative and financial reports, helping them to monitor investments and continually align funding with the most effective innovations. 5

KEY ELEMENTS OF THE INNOVATION FUND

Rapid, flexible resources building a pathway to scale

• Pooled fund of $5 million/year.

• Transparent criteria and process for selection of projects, including defined metrics for measuring success/impact.

• Provision of rapid, flexible resources during the early stages of a project’s life cycle, building a pathway to scale-up by governments and donors.

• Advisory Committee comprised of HIV experts and lead funders working together to recommend the highest-potential projects for seed funding.

• External/private sector expertise leveraged to strengthen projects as needed.

• Five year initial phase from 2011 to 2015, with annual review of results and impact.

INNOVATION FUND TARGET AREAS FOR INVESTMENT

Investing for impact

Solutions for “Last Mile” Delivery

• Strengthen drug and local supply chains • Ensure drug delivery and uptake by hardest-to-reach populations• Facilitate improved disease reporting, test result delivery, and treatment monitoring• Develop open-source mobile technology for integrated health services

Innovation in the Youth Agenda

• Reimagine youth-friendly HIV/AIDS prevention and treatment platforms • Empower youth through technology, social networks, and other new media• Enable peer-to-peer communication and support to reduce stigma

Strengthening Families and Communities

• Build social and economic systems that incentivize well-being and facilitate access to health care for the hardest-to-reach • Design resources for community-based health care and education

Optimizing Management Systems

• Maximize cost effectiveness of interventions and outcomes• Improve data use and management

INNOVATION FUND PROJECT SELECTION CRITERIA

Breaking through bottlenecks, delivering results, positioning for scale-up

• Focus on new interventions and technologies, or innovations to current approaches that contribute to reducing the impact of HIV/AIDS on women and children.

• IIdentify specific bottlenecks to be addressed and show how a project can help change the HIV/AIDS landscape.

• Be evidence-based and contribute on-the-ground results within 2–3 years.

• Demonstrate how “proof-of-concept” could lead to scale-up and funding by governments and donors.

• lBuild on partnerships on the ground, link with national oversight.

• Use existing global and national data and indicators to measure projects’ success.

• lBe fundable with approximately $500K per project.

INNOVATION: RAPID SMS MOBILE TECHNOLOGY

RapidSMS improves access to HIV test results and services for women and infants

Problem Transportation barriers and logistical challenges lead to slow reporting of HIV test results, delaying early infant diagnosis and inhibiting treatment for mothers and infants.

Solution Use of RapidSMS phone technology to drastically reduce wait time for results.

Results• 50% improvement in the delivery of HIV results for infants.• Helps ensure treatment availability and adherence.

Benefits• Speed — Wait time for test results cut from months to days.• Cost — No SMS cost for clinic staff.• Scale — Potential for national scale at low cost. • Reporting — Web portal provides national view of HIV rates and treatment.

All pregnant mothers are offered testing

Blood sample taken at local clinic

Samples packed and logged

Results processed and sent to clinic via SMS

Mother retrieves blood test results from clinic and results are logged

If HIV+, child starts treatment. If negative, child retested in six months

Results received by clinic worker and logged

SMS sent to hub clinic to confirm transport of samples

Lab receives samples

Mother is contacted

Baby born to HIV+ mother

1

3

4 5

910

11

12

14

13

2

CLINIC

HUB CLINIC

Dried Blood Sample

(DBS)

Samples transported to district hub clinic

Hub clinic receives and logs samples

Hub aggregates samples and sends to lab

6

7

8

Dried Blood Sample (DBS)

Dried Blood Sample (DBS)

Dried Blood Sample (DBS)

Dried Blood Sample (DBS)

Dried Blood Sample (DBS)

Dried Blood Sample (DBS)

Dried Blood Sample (DBS)

Dried Blood Sample (DBS)

Dried Blood Sample (DBS)

LAB

Dried Blood Sample (DBS)

Dried Blood Sample (DBS)

Dried Blood Sample (DBS)

SMS

OPPORTUNITY

UNICEF as a Partner for Innovation UNICEF is present in more than 150 developing countries, and has a long history of identifying and scaling innovative solutions for children. We are looking for partners who share our belief that the next step in the fight against HIV/AIDS calls for new collaboration models and a willingness to embrace innovation.

GBCHealth as Co-Sponsor GBCHealth is a global leader dedicated to business leadership and cross-sector collective action to overcome the major public health challenges of our time. GBCHealth works with over 200 global companies who are united in their desire to improve global health.

Become a Seed Funder

Make a substantial, multi-year contribution to help seed the Fund. Join the Fund’s Advi-sory Committee — a multi-disciplinary group of corporate and philanthropic leaders and top HIV experts — and leverage your network to engage other funders and partners.

CONTACT US

For more information, please contact:

Rajesh Anandan Senior Vice President Private Sector Partnerships | UNICEF VenturesU. S. Fund for UNICEF(212) 992-2646ranandan@unicefusa.org

Colleen Galbraith Manager, Corporate Partnerships U. S. Fund for UNICEF(212) 922-2635cgalbraith@unicefusa.org